R. Breyer-Kohansal (Vienna, Austria), J. Lopez-Campos (Seville, Spain)
Spirometric screening and survey of knowledge on COPD and smoking in Spanish political representatives: The ConSePOC study
J. B. Soriano, F. García-Rio, M. Miravitlles, M. Calle-Rubio, A. Jovell, E. Fernandez, J. M. Rodríguez Gonzalez-Moro, M. C. Montero, M. A. Planchuelo, J. Casafont, J. Ruiz-Manzano, J. Ancochea (Bunyola, Madrid, Barcelona, A Coruña, Spain)
|  |
Improving and redesigning chronic obstructive pulmonary disease services: A systematic improvement approach
P. Duncan, C. Thompson, C. Blackaby, Z. Lord, O. Okosi, H. Wall, A. Porter, K. Holton, A. Moger, M. Kearney, R. Winter, S. L. Hill (Leicester, London, United Kingdom)
|  |
The effect of early stages of COPD on resource use and health-care costs
P. Menn, J. Heinrich, R. Huber, R. Jörres, J. Jürgen, S. Karrasch, A. Peters, H. Schulz, R. Holle (Neuherberg, Muenchen, Germany)
| |
The impact of a respiratory in-reach service into the emergency assessment unit (EAU) on treatment, length of stay, and re-admission rates
F. Johnstone, L. Dowson (Wolverhampton, United Kingdom)
|  |
The economic burden of COPD in a Danish municipality
N. Maltbæk, J. Pagh Maltbæk, M. Nyhus Andreasen (Roskilde, Copenhagen, Denmark)
| |
Cost-effectiveness of tiotropium versus salmeterol: A trial-based analysis followed by a model-based extrapolation
M. Hoogendoorn, M. Al, J. M. Graf von der Schulenburg, D. Bowles, B. Monz, H. Schmidt, J. Lungershausen, M. Rutten-van Molken (Rotterdam, Netherlands; Hanover, Bielefeld, Ingelheim, Germany)
| |
Clinical and pharmacy-economical reasonability of the choice of fixed combination of fluticasone/salmeterol in the curing of bronchial asthma in the country with limited financing of the public health
D. Ruzanov, E. Davidovskaya, T. Baranovskaya (Gomel, Minsk, Belarus)
| |